A complete application in a minute — tailored resume and cover letter, ready to send.
Quotient Therapeutics in Cambridge, UK seeks a Senior Research Associate / Associate Scientist to advance molecular biology workflows in a high‑throughput platform. You will extract DNA/RNA from human samples, prepare sequencing libraries, and optimize automated workflows while collaborating with Histology, Flow Cytometry and Assay Development teams.
The role emphasizes quality control, troubleshooting, and hands‑on lab work in a fast‑paced biotechnology environment, with opportunities to mentor
Cambridge, UK
Position Summary:
We are seeking an experienced Senior Research Associate / Associate Scientist to join our Molecular Biology platform within the High Throughput Laboratory.
Reporting to the Scientific Manager, this role will be responsible for delivering high-quality molecular biology workflows that underpin Quotient's somatic genomics platform. Working closely with Histology, Flow Cytometry, Assay Development, Automation and Data Science, you will support the processing of human tissue-derived samples from nucleic acid extraction through to sequencing-ready libraries.
The successful candidate will combine excellent technical expertise with a passion for continuous improvement, working collaboratively across scientific teams to optimise workflows, troubleshoot technical challenges and help implement new technologies into routine laboratory operations.
This role is ideally suited to someone who enjoys operating in a fast-paced biotechnology environment, is passionate about molecular biology, and is excited by the opportunity to contribute to a growing high-throughput genomics platform.
Responsibilities:
Qualifications:
Values and Behaviors:
About Quotient:
Quotient Therapeutics is a privately‑held, early stage company developing breakthrough medicines informed by natural somatic genetic diversity present in patients. Through our work in somatic genomics, we are forging a new status quo for biopharma research and development across a broad pipeline of internal and partnered programs.
The company was founded by Flagship Pioneering, an innovative enterprise that conceives, creates, resources, and grows first‑in‑category life sciences companies. Flagship Pioneering has created over 100 groundbreaking companies over the past twenty years, all of which are pioneering novel and proprietary biological, industrial, and engineering approaches to solve major needs in human health and sustainability. These companies include Moderna (MRNA), Generate Biomedicines, Sana Biotechnology (SANA), Tessera Therapeutics, Evelo Biosciences (EVLO), Indigo Agriculture, Seres Therapeutics (MCRB), and Syros Pharmaceuticals (SYRS).
Quotient Therapeutics and Flagship Pioneering are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.